# Selenium as Augmentation Treatment for Sertraline Resistant Major Depression

> **NCT02890212** · NA · SUSPENDED · sponsor: **University of Sao Paulo General Hospital** · enrollment: 60 (estimated)

## Conditions studied

- Major Depression

## Interventions

- **DIETARY_SUPPLEMENT:** selenium supplementation
- **DIETARY_SUPPLEMENT:** placebo

## Key facts

- **NCT ID:** NCT02890212
- **Lead sponsor:** University of Sao Paulo General Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2005-08
- **Primary completion:** 2025-12
- **Final completion:** 2025-12
- **Target enrollment:** 60 (ESTIMATED)
- **Why stopped:** due to COVID19 pandemic
- **Last updated:** 2024-05-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02890212

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02890212, "Selenium as Augmentation Treatment for Sertraline Resistant Major Depression". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02890212. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*